Veronica Luzzi
Washington University in St. Louis
11 Papers
242 Citations
Veronica Luzzi is an academic researcher from Washington University in St. Louis. The author has contributed to research in topics: Laser capture microdissection & Gene expression profiling. The author has an hindex of 10, co-authored 11 publications.
Chat about Author
Papers
Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis.
TL;DR: It is demonstrated that two rounds of transcript amplification can generate accurate and reproducible gene expression profiles using high density oligonucleotide microarrays, starting with as little as 10 ng of total RNA.
142
Effects of hemoglobin (Hb) E and HbD traits on measurements of glycated Hb (HbA1c) by 23 methods.
Randie R. Little,Curt L. Rohlfing,Steve Hanson,Shawn Connolly,Trefor Higgins,Cas Weykamp,Mario D'Costa,Veronica Luzzi,William E. Owen,William L. Roberts +9 more
TL;DR: Some current HbA(1c) methods show clinically significant interferences with samples containing HbE or HbD traits, and ion-exchange chromatograms must be carefully examined to identify possible interference from these Hb variants.
Expression Profiling of Ductal Carcinoma in Situ by Laser Capture Microdissection and High-Density Oligonucleotide Arrays
TL;DR: In this paper, the authors demonstrate how a modest use of laser capture microdissection is sufficient to isolate nanogram quantities of high quality RNA, together with the use of several internal standards and microcapillary electrophoresis of input RNA, two rounds of linear molecular amplification have been used to generate sufficient quantities of labeled target for hybridization to high-density oligonucleotide expression arrays.
127
Expression profiling of ductal carcinoma in situ by laser capture microdissection and high-density oligonucleotide arrays
TL;DR: This report demonstrates how a modest use of laser capture microdissection is sufficient to isolate nanogram quantities of high-quality RNA and compares the expression profiles of nonmalignant human breast epithelium and adjacent ductal carcinoma in situ lesions from breast cancer patients.
Analytic Performance of Immunoassays for Drugs of Abuse Below Established Cutoff Values
Veronica Luzzi,Al N. Saunders,John W. Koenig,John Turk,Stanley F. Lo,Uttam Garg,Dennis J. Dietzen +6 more
TL;DR: The precision of three commercial immunoassay systems for drugs-of-abuse screening is adequate to detect drugs below SAMHSA cutoffs, and knowledge of the positive predictive values of screening Immunoassays at lower cutoff concentrations could enable efficient use of confirmatory testing resources and improved detection of illicit drug use.